PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 4, 2026Haematologica0 citationsOpen Access

Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report

View Full Paper
COCarmen de Ramon OrtizHAHana AbouzeidCBChiara De Bernardi

Key Points

  • To explore how azacitidine-induced remission can facilitate allogeneic transplantation in patients with TET2/BCOR-mutant relapsed lymphoma.
  • Case report detailing the treatment of a patient with TET2/BCOR-mutant lymphoma
  • Administration of azacitidine prior to transplantation
  • Monitoring of remission status before allogeneic transplant
  • Patient achieved remission after azacitidine treatment
  • Successfully underwent allogeneic transplantation
  • Demonstrated potential for azacitidine in similar lymphoma cases

Abstract

Not available.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ortiz et al. (2026) studied this question.

synapsesocial.com/papers/69d0afb4659487ece0fa5c37https://doi.org/10.3324/haematol.2025.300314
Ask AI
Helpful
Bookmark
Share
View Full Paper